MGI Pharma promotes Senior VP-International & Corporate Development William Spengler to senior VP and CFO, succeeding James Hawley, who has left the company. Spengler joined MGI in October 2005; he previously spent over 14 years at Bristol-Myers Squibb, where he worked in finance, planning and business development...
You may also be interested in...
In its “robust, holistic hub” online, firms in the VMS product supply chain can determine their needs, “by product, solution or delivery formats,” and use a “comprehensive and unique portfolio” to “turn natural sources into shelf-ready products.”
Plus deals involving Astellas/Actinium, Sosei/PharmEnable, Aadi/EOC Pharma, BeiGene/Strand, Chi-Med/Inmagene, Alteogen/Intas, Sosei/AbbVie, Y-Biologics/3D Medicines.
If J&J’s gamble on a single dose pays off, it could rapidly advance the fight against SARS-CoV2 – but a second study will provide a safety net.